To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to medicinal cannabis for people who are eligible.
25 April 2022
The Government has amended the law to allow specialist doctors in the United Kingdom to prescribe cannabis-based products, where clinically appropriate and in the best interests of patients. Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based products for medicinal use. Until that evidence base is built, prescribers will remain reticent to prescribe and no decision can be made by the NHS on routine funding. We continue to call on manufacturers to conduct this research and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.